Academic Journal
Q1Frontiers in Aging Neuroscience
About Frontiers in Aging Neuroscience
Frontiers in Aging Neuroscience is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q1, with an SJR of 1.507 and H-index of 146.
Coverage: 2009-2026. Research categories: Cognitive Neuroscience (Q1); Aging (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Dementia and Cognitive Impairment Research; Alzheimer's disease research and treatments; Functional Brain Connectivity Studies; Parkinson's Disease Mechanisms and Treatments; Neuroinflammation and Neurodegeneration Mechanisms; Neurological Disease Mechanisms and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Is easy-to-read easy for everyone? An eye-tracking study across the adult lifespan
Sergio Navas-León, Jon Andoni Duñabeitia
2026-10-06 · DOI: 10.3389/fnagi.2026.1916339Reduced serum LEFTY2 and disease-dependent biomarker associations in Alzheimer’s disease: an exploratory study
Wei Wuli, Raymond Y. Lo, Horng-Jyh Harn, Tzyy-Wen Chiou et al.
2026-10-06 · DOI: 10.3389/fnagi.2026.1955495Transcriptomic analysis identifies candidate molecular mechanisms underlying SCF+G-CSF-reduced neuropathology in aged APP/PS1 mice
Afua Addo, Bin Li, Sasidhar Murikinati, Robert Gardner et al.
2026-10-06 · DOI: 10.3389/fnagi.2026.1705436Association of statin use with reduced risk of Alzheimer’s disease: findings in UK Biobank
Hui Yang, Can Zhu, Jialu He, Yan Wei et al.
2026-10-06 · DOI: 10.3389/fnagi.2026.1961033Epigenetics in Alzheimer’s disease: from molecular mechanisms to emerging novel biomarkers
Elisabetta D’Aversa, Miriana Grisafi, Salvatore Pernagallo, Francesca Salvatori et al.
2026-10-05 · DOI: 10.3389/fnagi.2026.1959361Dual-scale assessment of motor dysfunction in older adults with locomotor dysfunction and its association with gait and muscle activation
Wen Liu, Chunxiao Lu, Lifeng Qian
2026-10-05 · DOI: 10.3389/fnagi.2026.1980454Atherosclerotic cardiovascular disease risk is associated with AT(N)V neuroimaging biomarkers and cognitive impairment in the health and aging brain study–health disparities cohort
Kimberly Espejo, Ryan Rulkens, Cellas A. Hayes, Joey A. Contreras et al.
2026-10-05 · DOI: 10.3389/fnagi.2026.1874472Hydrogen gas and olfactory dysfunction in Alzheimer’s disease: the Hydrogen–Olfactory–Limbic hypothesis
Ligao Bao, Dunfu Eer
2026-10-02 · DOI: 10.3389/fnagi.2026.1937419Comparative efficacy of non-pharmacological interventions for amnestic mild cognitive impairment: a network meta-analysis
Baofang Zhang, Xuanling Li, Qian Zhao, Shuqun Zhang et al.
2026-10-02 · DOI: 10.3389/fnagi.2026.1878590Digital mobility assessment using wearable devices in people with Parkinson’s disease: a feasibility and implementation study in Ghana (TraPCAf) compared with a UK cohort
Metin Bicer, Cameron Kirk, Mary Agoriwo, Momodou Cham et al.
2026-10-02 · DOI: 10.3389/fnagi.2026.1899045Rasch-based classification of post-stroke balance ability: dimensionality and clinical validation of the BESTest and S-BESTest
Thitimard Winairuk, Marco Y. C. Pang, Sirod Sirisup, Vitoon Saengsirisuwan et al.
2026-10-02 · DOI: 10.3389/fnagi.2026.1889177Associations between inflammatory-lipid indices and clinical outcomes in ischemic stroke patients treated with mechanical thrombectomy
Ao Qian, Jia Duan, Wenli Xing, Longyi Zheng et al.
2026-10-02 · DOI: 10.3389/fnagi.2026.1919645Longitudinal changes in hand dominance and manual dexterity in normal aging and mild cognitive impairment (MCI): a kinematic study
Olena Vasylenko, Claudia Rodríguez-Aranda
2026-10-02 · DOI: 10.3389/fnagi.2026.1921208Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
Jun Kang, Yongbo Duan, Jiaxuan Bi, Jiangping Liu et al.
2026-10-02 · DOI: 10.3389/fnagi.2026.1952923Eye-movement-based machine learning for identifying Parkinson’s disease dementia in a retrospective cohort: an interpretable model-development study
Jing Wu, Qing Liu, Song Yang, Yuqing Zhang et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1935091Cardiorespiratory fitness is associated with cerebral oxygen extraction in Alzheimer’s disease
Paul J. Kueck, Zachary D. Green, Raechel Camones, Casey S. John et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1943472Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 Christchurch
Carlye Frisch, Lauren Baker, Gayathri Srinivasan, Albert E. Mintah et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1856154Circulating and cerebrospinal fluid soluble TREM2 levels and risk of perioperative neurocognitive disorders in surgical patients: a systematic review and meta-analysis
Haotian Wu, Yujie Wang, Zhifeng Gao, Huan Zhang et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1899745No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer’s disease neuroimaging initiative
Tia Warrick, Manali Misra, Stephen Kataria, Jahnavi Patel et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1942662Auditory performance and cortical plasticity in blind individuals with sensorineural hearing loss: insights into dual sensory impairment
Min Young Kwak, Jeong-Sug Kyong, Hyo Jung Choi, Yong-Hwi An et al.
2026-10-01 · DOI: 10.3389/fnagi.2026.1769582Reviews
Community Reviews
Version History
October 4, 2026 at 8:51 pm
September 25, 2026